Lack of CD8 <sup>+</sup> T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer
Brendan Horton(University of Chicago), Stefani Spranger(University of Chicago)
Cited by 127
Related Papers
Impact of oncogenic pathways on evasion of antitumour immune responses
|Nature reviews. Cancer|2018|652
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
|Journal for ImmunoTherapy of Cancer|2014|543